Long-term survival following total pancreatectomy and superior mesenteric-portal vein resection for pancreatic ductal adenocarcinoma: A case report

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with few therapeutic options. At present, surgical resection remains the only potential curative treatment for PDAC. However, only 15–20% of patients with PDAC are eligible for lesion resection. Total pancreatectomy (TP) and superior me...

Descripción completa

Detalles Bibliográficos
Autores principales: TONG, HAN-XING, ZHANG, LEI, RONG, YE-FEI, WANG, DAN-SONG, KUANG, TIAN TAO, XU, XUE-FENG, LOU, WEN-HUI, JIN, DA-YONG
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246678/
https://www.ncbi.nlm.nih.gov/pubmed/25435983
http://dx.doi.org/10.3892/ol.2014.2628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246678/
https://www.ncbi.nlm.nih.gov/pubmed/25435983
http://dx.doi.org/10.3892/ol.2014.2628

Ejemplares similares